[Sandostatin in the treatment of diarrhea of different origins].
Antidiarrheal action of sandostatin (octreotide) was studied in dumping syndrome, diabetic enteropathy, short-bowel syndrome, Crohn's disease and ulcerative colitis. Sandostatin proved effective in diarrhea of secretory, motor and osmotic origin. Dumping syndrome, diabetic enteropathy, Crohn's disease and short-bowel syndrome responded completely. In ulcerative colitis the effect was paradoxical: intensive diarrhea discontinued, but moderate diarrhea became more intensive. Sandostatin indications in ulcerative colitis should receive further investigations.
D000930:Antidiarrheals / Q000008:administration & dosage*; D003672:Defecation / Q000187:drug effects; D003967:Diarrhea / Q000188:drug therapy* / Q000209:etiology; D004341:Drug Evaluation; D006801:Humans; D007279:Injections, Subcutaneous; D015282:Octreotide / Q000008:administration & dosage*; D013997:Time Factors
D000930:Antidiarrheals; D015282:Octreotide
Sandostatin pri lechenii diarei razlichnogo geneza.